Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 698

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 698
---
15, 2025.

403

TABLE OF CONTENTS

(7)

Consists of 3,987 shares held directly by Dr. Ives and 10,462 shares of common stock underlying options that are vested and exercisable within 60 days of January 15, 2025.

(8)

Consists of 4,287 shares held directly by Dr. Shiff and 9,228 shares of common stock underlying options that are vested and exercisable within 60 days of January 15, 2025.

(9)

Consists of 2,697 shares of common stock held directly by Dr. Moltke and 6,611 shares of common stock underlying options that are vested and exercisable within 60 days of January 15, 2025.

(10)

Based solely on the Form 4 filed by Dr. Goncalves on April 9, 2024. Dr. Goncalves resigned from her role as Chief Medical Officer of Cara effective April 16, 2024.

(11)

Includes 37,605 shares of common stock, 2,377 RSUs that vest within 60 days of January 15, 2025, and 161,972 shares of common stock underlying options that are vested and exercisable within 60 days of January 15, 2025.

<div align='center'>404</div>

TABLE OF CONTENTS

PRINCIPAL STOCKHOLDERS OF TVARDI The following table sets forth information regarding beneficial ownership of Tvardi’s capital stock as of January 15, 2025 by: • each person, or group of affiliated persons, known by Tvardi to beneficially own more than 5% of its common stock; • each of Tvardi’s directors; • each of Tvardi’s named executive officers; and • all of Tvardi’s current executive officers and directors as a group. Tvardi has determined beneficial ownership in accordance with the rules and regulations of the SEC, and the information is not necessarily indicative of beneficial ownership for any other purpose. Except as indicated by the footnotes below, Tvardi believes, based on information furnished to Tvardi, that the persons and entities named in the table below have sole voting and sole investment power with respect to all shares that they beneficially own, subject to applicable community property laws. Applicable percentage ownership is based on 48,758,868 shares of Tvardi’s common stock outstanding as of January 15